Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Dehm

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Hormones & Cancer|January 12, 2013
Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progressionMichael D Nyquist, Scott M Dehm
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2023
Targeting the Androgen Signaling Axis in Prostate CancerCharles Dai, Scott M Dehm, Nima Sharifi
Endocrine-Related Cancer|March 23, 2016
Clonal origin and spread of metastatic prostate cancerJamie L Van Etten, Scott M Dehm
The Journal of Biological Chemistry|April 26, 2012
Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signalSiu Chiu Chan, Yingming Li, Scott M Dehm
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2018
AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?Scott M Dehm, Bruce Montgomery, Stephen R Plymate
Advances in Urology|September 8, 2012
Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancerManish Kohli, Rui Qin, Rafael Jimenez, et al.
Gene|June 20, 2006
The modification of Sp3 isoforms by SUMOylation has differential effects on the SRC1A promoterDanielle J P Ellis, Scott M Dehm, Keith Bonham
BMC Genomics|April 21, 2018
Indel detection from DNA and RNA sequencing data with transIndelRendong Yang, Jamie L Van Etten, Scott M Dehm
Nature Cancer|May 13, 2025
CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancerJacob J Orme, Emmanuel S Antonarakis, Scott M Dehm
Oncogene|September 6, 2002
The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylasesCalley L Kostyniuk, Scott M Dehm, Danielle Batten, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Hormones & Cancer|January 12, 2013
Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progressionMichael D Nyquist, Scott M Dehm
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2023
Targeting the Androgen Signaling Axis in Prostate CancerCharles Dai, Scott M Dehm, Nima Sharifi
Endocrine-Related Cancer|March 23, 2016
Clonal origin and spread of metastatic prostate cancerJamie L Van Etten, Scott M Dehm
The Journal of Biological Chemistry|April 26, 2012
Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signalSiu Chiu Chan, Yingming Li, Scott M Dehm
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2018
AR-Variant-Positive CTC: A Surrogate for a Surrogate for Taxane Therapy Outcome?Scott M Dehm, Bruce Montgomery, Stephen R Plymate
Advances in Urology|September 8, 2012
Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancerManish Kohli, Rui Qin, Rafael Jimenez, et al.
Gene|June 20, 2006
The modification of Sp3 isoforms by SUMOylation has differential effects on the SRC1A promoterDanielle J P Ellis, Scott M Dehm, Keith Bonham
BMC Genomics|April 21, 2018
Indel detection from DNA and RNA sequencing data with transIndelRendong Yang, Jamie L Van Etten, Scott M Dehm
Nature Cancer|May 13, 2025
CHD1 status drives divergent metabolic pathways in SPOP-mutant prostate cancerJacob J Orme, Emmanuel S Antonarakis, Scott M Dehm
Oncogene|September 6, 2002
The ubiquitous and tissue specific promoters of the human SRC gene are repressed by inhibitors of histone deacetylasesCalley L Kostyniuk, Scott M Dehm, Danielle Batten, et al.
Pageof 13